To The Moon

$ARM Holdings(ARM)$ The recent correction across the AI and semiconductor sectors has given me another opportunity to accumulate more $Arm Holdings (ARM)$. Similar to my approach with SOXL, I see the latest weakness as an opportunity rather than a reason to panic. Market sentiment has turned increasingly negative as investors question whether massive AI capital expenditures can generate sufficient returns. The recent US midterm election results and concerns over potential Democratic policies towards AI development have added further uncertainty, triggering another wave of selling across technology stocks. However, I feel ARM has been caught up in this broader market pessimism, and the extent of its pullback looks excessive to me. What makes me

$Direxion Daily Semiconductors Bull 3x Shares(SOXL)$ The recent massive pullback across the AI and semiconductor sectors has caught my attention, and I have started collecting more Direxion Daily Semiconductor Bull 3X Shares (SOXL) gradually. The market seems to be shifting from excitement about AI growth towards concerns about monetisation and return on investment. With technology giants continuing to pour billions into AI infrastructure, investors are becoming increasingly impatient about when these massive capital expenditures will translate into meaningful revenue and sustainable profits. This has triggered selling pressure across semiconductor stocks, even among companies with relatively strong fundamentals and promising long-term growth

$Delta Air Lines(DAL)$ DAL: sold my positions on DAL at $82 for a small profit after my covered call closed in the money at $87.2.  Bought them at 81.71 on 21st Sept to sell covered call and had been able to sell for few rounds including the period when the stock was trading below holding price.  Nevertheless was able to sell this final round slightly above cost as well as profiting for the multiple rounds of premium collection via covered calls selling.  Overall profitable trade and partial hedge on oil movement trade. So when oil price came down this week, airline stock went up.

$United States Oil Fund LP(USO)$ USO: bought shares of USO to cover my net short positions at $160.  In prior weeks, USO was trading at peak of $172.82 and my short call positions were assigned. There was holding net short shares ar $160.  Determined that oil price would be lower within weeks, I held on to the positions and sold short put at same strike of $160 to capture more premium.  USO closed $148.41, dropping after US midterms results favouring Democrats so the market was reacting to potentially Iran was deescalation.  Though the potential upside gain was trimmed for this case, the outcome of the trade was intended and I get to cancelled out my net short positions and clear up some trading margins ready for next week.

$MARA 20261204 9.0 CALL$ Covered call at a much lower price than my cost. Not expecting it to spike with such negative sentiments on data centers (even though it is not even a data center yet). The btc bag it holds probably worth much more than their own assets.  Nonetheless, bullish on btc and hence bullish on their bag. 

$COIN 20261204 165.0 CALL$ Covered call at a much lower price than I was assigned. It doesnt look good on the short term but still remains one of the leaders in tokenisation and crypto trading. Hopefully the prediction markets pick up also.

$ORCL DIAGONAL 261218/261120 CALL 140.0/CALL 165.0$ Rolling down to collect more premium.  But it caps at a lower strike. If oracle spikes, means I have to stop out and close both together. Otherwise losses keep accumulating as it goes up 

$CRCL 20261113 110.0 CALL$ Close the call for credit 

$ONDS 20261113 5.0 PUT$ Base case: Ondas is more likely to miss than beat the current Q3 EPS consensus of -$0.138 , although the unusually wide estimate range means a small beat remains plausible if acquisition-related costs were materially lower than analysts expect. [Symbol:ONDS|Ondas Holdings (ONDS)] is due to report 2026Q3 on 2026-11-12 before the US market opens . Consensus is for revenue of $148.0 million and EPS of -$0.138 (nine analysts), with EPS estimates spanning -$0.19 to -$0.08 . Why I lean toward a miss: The Q2 miss was substantial, not marginal. EPS was -$0.14 versus -$0.081 expected: a $0.059/share shortfall, or 72.8% worse than consensus (calculator result). At the same time, Q2 revenue beat by $15.8 millio

$CLSK 20261113 5.0 PUT$ The immediate driver was the KBW rating cut to “Market Perform” from “Outperform” for CleanSpark (CLSK) watchlist . The market treated it as a reassessment of the upside case rather than a routine change: shares fell 16.23% to US$6.83 in that session, with roughly 30.8 million shares traded versus a daily average above 18 million, indicating unusually forceful selling. Tiger News What the move likely reflected: Expectation reset: A downgrade from an outperform-equivalent rating signals that the analyst no longer sees sufficiently compelling risk-adjusted upside at that point. For a Bitcoin miner, whose equity is highly sensitive to Bitcoin, network difficulty, power costs, and financing needs, that c

$Direxion Daily Semiconductors Bull 3x Shares(SOXL)$ The recent massive pullback across the AI and semiconductor sectors has caught my attention, and I have started collecting more Direxion Daily Semiconductor Bull 3X Shares (SOXL) gradually. The market seems to be shifting from excitement about AI growth towards concerns about monetisation and return on investment. With technology giants continuing to pour billions into AI infrastructure, investors are becoming increasingly impatient about when these massive capital expenditures will translate into meaningful revenue and sustainable profits. This has triggered selling pressure across semiconductor stocks, even among companies with relatively strong fundamentals and promising long-term growth

$ARM Holdings(ARM)$ The recent correction across the AI and semiconductor sectors has given me another opportunity to accumulate more $Arm Holdings (ARM)$. Similar to my approach with SOXL, I see the latest weakness as an opportunity rather than a reason to panic. Market sentiment has turned increasingly negative as investors question whether massive AI capital expenditures can generate sufficient returns. The recent US midterm election results and concerns over potential Democratic policies towards AI development have added further uncertainty, triggering another wave of selling across technology stocks. However, I feel ARM has been caught up in this broader market pessimism, and the extent of its pullback looks excessive to me. What makes me

$ONDS 20261113 5.0 PUT$ Base case: Ondas is more likely to miss than beat the current Q3 EPS consensus of -$0.138 , although the unusually wide estimate range means a small beat remains plausible if acquisition-related costs were materially lower than analysts expect. [Symbol:ONDS|Ondas Holdings (ONDS)] is due to report 2026Q3 on 2026-11-12 before the US market opens . Consensus is for revenue of $148.0 million and EPS of -$0.138 (nine analysts), with EPS estimates spanning -$0.19 to -$0.08 . Why I lean toward a miss: The Q2 miss was substantial, not marginal. EPS was -$0.14 versus -$0.081 expected: a $0.059/share shortfall, or 72.8% worse than consensus (calculator result). At the same time, Q2 revenue beat by $15.8 millio

$United States Oil Fund LP(USO)$ USO: bought shares of USO to cover my net short positions at $160.  In prior weeks, USO was trading at peak of $172.82 and my short call positions were assigned. There was holding net short shares ar $160.  Determined that oil price would be lower within weeks, I held on to the positions and sold short put at same strike of $160 to capture more premium.  USO closed $148.41, dropping after US midterms results favouring Democrats so the market was reacting to potentially Iran was deescalation.  Though the potential upside gain was trimmed for this case, the outcome of the trade was intended and I get to cancelled out my net short positions and clear up some trading margins ready for next week.

$Delta Air Lines(DAL)$ DAL: sold my positions on DAL at $82 for a small profit after my covered call closed in the money at $87.2.  Bought them at 81.71 on 21st Sept to sell covered call and had been able to sell for few rounds including the period when the stock was trading below holding price.  Nevertheless was able to sell this final round slightly above cost as well as profiting for the multiple rounds of premium collection via covered calls selling.  Overall profitable trade and partial hedge on oil movement trade. So when oil price came down this week, airline stock went up.

$CLSK 20261113 5.0 PUT$ The immediate driver was the KBW rating cut to “Market Perform” from “Outperform” for CleanSpark (CLSK) watchlist . The market treated it as a reassessment of the upside case rather than a routine change: shares fell 16.23% to US$6.83 in that session, with roughly 30.8 million shares traded versus a daily average above 18 million, indicating unusually forceful selling. Tiger News What the move likely reflected: Expectation reset: A downgrade from an outperform-equivalent rating signals that the analyst no longer sees sufficiently compelling risk-adjusted upside at that point. For a Bitcoin miner, whose equity is highly sensitive to Bitcoin, network difficulty, power costs, and financing needs, that c

$ONDS 20261113 4.5 PUT$ Signal: options are pricing an unusually large earnings-related move, not a reliably bullish or bearish outcome. An IV of 101% at the 87th percentile means implied volatility is higher than roughly 87% of its historical observations—so event-risk premium is elevated and near-term options are expensive relative to their own history. For Ondas Holdings (ONDS) watchlist , the 2026-11-12 earnings release is scheduled before the US market opens. A 101% annualised IV translates mechanically to roughly a ±11.8% one-standard-deviation move over five calendar days; that is a pricing-implied range, not a forecast of direction. What it suggests: The market expects a potentially material reaction to earnings or

$UPST 20261113 20.0 PUT$ The 6,000-contract buy of Upstart (UPST) watchlist $25 calls expiring 2026-11-20 is a bullish, high-conviction volatility/directional signal , but not proof that the buyer expects—or has unhedged exposure to—a move above $25. The trade was executed on 2026-11-02 at $0.59 per contract , representing $354,000 in premium paid, while UPST traded at $21.21 . The $25 strike was 17.87% above the underlying at execution; including the premium, the buyer’s expiration breakeven was about $25.59 , or 20.65% above spot. As of 2026-11-07, UPST was $21.89 , leaving the strike 14.21% out of the money . The Nov. 20 $25 call now shows 7,811 contracts of open interest , though open interest alone cannot confirm tha

$MARA 20261204 9.0 CALL$ Covered call at a much lower price than my cost. Not expecting it to spike with such negative sentiments on data centers (even though it is not even a data center yet). The btc bag it holds probably worth much more than their own assets.  Nonetheless, bullish on btc and hence bullish on their bag. 

$COIN 20261204 165.0 CALL$ Covered call at a much lower price than I was assigned. It doesnt look good on the short term but still remains one of the leaders in tokenisation and crypto trading. Hopefully the prediction markets pick up also.

$ORCL DIAGONAL 261218/261120 CALL 140.0/CALL 165.0$ Rolling down to collect more premium.  But it caps at a lower strike. If oracle spikes, means I have to stop out and close both together. Otherwise losses keep accumulating as it goes up 

What a monster quarter from $Xeris Pharmaceuticals Inc(XERS)$ Stock is pushing brand-new 52-week highs ($11.36+ pre-market) and it's completely deserved. Look at the numbers they just reported: $107.2M in revenue (beat by $5.5M) and positive GAAP EPS of $0.06 (crushed the -$0.01 estimate). Recorlev is taking massive market share in Cushing's, gross margins are holding above 86%, and management just gave a long-term 2030 revenue target exceeding $1 Billion. Add in the fact that they retired $34M in convertible debt earlier and their Phase 3 for XP-8121 starts around year-end, and this isn't just a speculative biotech anymore—it's a profitable commercial compounder. My execution plan: Current: ~$10.41 – $10.75 (Surging to $11.36+) Buy the retest: $1

Huge congratulations to myself for snagging the #1 spot on the Yearly Leaderboard! 🥇😆🤣 Walking away with a +66.23% return is a solid win, even if that massive drop definitely took a bite out of my overall profit gains for the year. ​Surviving the volatility with my US options plays was a wild ride, but finishing on top makes the grind worth it. Time to reset the charts and start strategizing—let's plan for an even bigger success next year! 📈🚀  

$CRCL 20261113 110.0 CALL$ Close the call for credit